Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Electronic Resource
    Electronic Resource
    Amsterdam : Elsevier
    Cytokine 6 (1994), S. 553 
    ISSN: 1043-4666
    Source: Elsevier Journal Backfiles on ScienceDirect 1907 - 2002
    Topics: Biology , Medicine
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    Oxford, UK : Blackwell Publishing Ltd
    Annals of the New York Academy of Sciences 511 (1987), S. 0 
    ISSN: 1749-6632
    Source: Blackwell Publishing Journal Backfiles 1879-2005
    Topics: Natural Sciences in General
    Notes: The glycosylated and the non-glycosylated recombinant human granulocyte-macrophage colony-stimulating factor (rh GM-CSF) expressed in Chinese hamster ovary cells and E. coli, respectively, were administered in rhesus monkeys either by the subcutaneous (three times daily) or intravenous route (6-hr infusions) for seven consecutive days. Within 24 hr peripheral white blood cells (WBC) increased 2-3-fold over normal values. Thereafter, the WBC increased steadily in a dose-dependent manner to reach maximum levels on the last day of or one day after the treatment period. The differential counts showed that neutrophils contributed to 50-80%, eosinophils to 10-20%, monocytes to 2-7%, and lymphocytes to 15–30% of the WBC rise. No effect was found on platelets and erythrocytes. After termination of treatment, WBC counts returned to normal levels within one week. Subcutaneously administered CSF was more effective in inducing leukocytosis than that injected intravenously. In addition to the rise in WBC, the administered rh GM-CSF also enhanced the oxidative metabolism and bactericidal activity of the circulating mature granulocytes isolated from the blood of monkeys treated with rh GM-CSF. These results show that glycosylated or non-glycosylated rh GM-CSF is both an effective stimulator of leukocytosis and a potent activator of the functional activity of mature granulocytes in vivo.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    ISSN: 1439-0973
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Summary The reactogenicity and immunogenicity of a new influenza subunit vaccine essentially containing only haemagglutinin and neuraminidase was studied in man. The vaccine was compared to commercially available vaccines, an adjuvant containing tween-ether split vaccine (800 IU per dose), and a fluid whole-virus vaccine (2100 IU per dose). Two dosages (700 and 2100 IU) of the fluid subunit vaccine were compared. All vaccines contained the virus strains recommended by the WHO for the 1975/76 season. In a double-blind study 399 volunteers were randomly selected to receive one of the four vaccines. The volunteers were examined for side-effects 24 and 48 hr after vaccination. Antibodies inhibiting haemagglutination were determined prior to and four weeks after vaccination. The subunit vaccine at 700 IU per dose caused significantly fewer local side effects than the comparable split vaccine, and resulted in significantly higher antibody titers against both influenza A strains. A comparison of the subunit and whole virus vaccines containing high dosages (2100 IU) showed striking differences in reactogenicity. Subunit vaccine was very well tolerated, whereas whole virus vaccine caused systemic reactions, including fever and headache, in 15% of the volunteers. No significant reactogenicity was seen with a high dosage of subunit vaccine (2100 IU) although this is a three-fold increase on the currently used European dosage. Antibody titers were significantly enhanced however.
    Notes: Zusammenfassung Eine neue, praktisch nur Hämagglutinin und Neuraminidase enthaltende Influenza-Subunit-Vakzine wurde im Hinblick auf Verträglichkeit und Immunogenität am Menschen untersucht. Zum Vergleich wurden ein im Handel befindlicher adjuvanshältiger Tween-Äther Spaltimpfstoff (Dosierung 800 IE) und eine Ganzvirusvakzine ohne Adjuvans (Dosierung 2100 IE) herangezogen. Zwei Dosierungen (700 und 2100 IE) der Subunit-Vakzine ohne Adjuvans wurden verglichen. Alle Impfstoffe enthielten die von der WHO für die Saison 1975/76 empfohlenen Virusstämme. Die Impfung wurde als Doppelblindstudie durchgeführt, wobei die 399 Probanden den vier Vakzinen randomisiert zugeordnet wurden. Die Probanden wurden 24 und 48 Stunden nach der Impfung im Hinblick auf Nebenwirkungen vom Impfarzt untersucht. Die hämagglutinationshemmenden Antikörper wurden vor und vier Wochen nach der Impfung bestimmt. Der niedrig dosierte Subunit-Impfstoff führte zu signifikant weniger lokalen Nebenreaktionen als die vergleichbar dosierte Spaltvakzine. Die Antikörperbildung war aber hinsichtlich der antikörperstimulierenden Wirkung gegen die in der Vakzine enthaltenen A-Stämme deutlich überlegen. Beim Vergleich der beiden hoch dosierten Vakzinen fiel besonders die gute Verträglichkeit der Subunit-Vakzine auf. Die Impfung mit der Ganzvirusvakzine hatte bei mehr als 15% der Probanden systemische Nebenreaktionen, wie Fieber und Kopfschmerz, zur Folge. In der Induktion von Antikörpern weist die Subunit-Vakzine leichte aber nicht signifikante Vorteile auf. Die Erhöhung auf das Zwei- bis Dreifache der derzeit in Europa üblichen Antigendosierung in der Subunit-Vakzine führt zu einer hoch signifikanten Wirksamkeitssteigerung.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    ISSN: 1476-4687
    Source: Nature Archives 1869 - 2009
    Topics: Biology , Chemistry and Pharmacology , Medicine , Natural Sciences in General , Physics
    Notes: [Auszug] Previous studies had demonstrated that animal cells can be entrapped in a viable state in alginate beads, providing preparations in which the cells are either embedded throughout the network of the bead3 or kept within the microcapsules, which are characterized by a shell of ...
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    Electronic Resource
    Electronic Resource
    Springer
    Medical microbiology and immunology 170 (1982), S. 255-264 
    ISSN: 1432-1831
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract After intravenous immunization of mice with any influenza A H3N2 drift strain attempts to restimulation of cytotoxic T cell (CTL) activities with the same virus or other drift period variants were unsuccessful for up to 6 weeks. Cross-stimulation 4–5 months after primary sensitization yielded, in most situations, positive but lower — as compared to primary — secondary cytotoxic T cell responses. Homotypic challenge was also effective after priming with some influenza A subtypes (A/E/72, A/PC/73, A/T/77) at this time.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 6
    Electronic Resource
    Electronic Resource
    Springer
    European journal of clinical microbiology & infectious diseases 13 (1994), S. S9 
    ISSN: 1435-4373
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract The possibility of predicting the clinical effects of cytokines from in vitro data is discussed, using GM-CSF as an example. GM-CSF incubated with bone marrow cells has been shown to induce proliferation and colony formation, predominantly of the colony-forming unit granulocyte and granulocyte-macrophage types. Daily treatment of normal monkeys with GM-CSF resulted in transient neutropenia followed by neutrophilia. After withdrawal of GM-CSF the neutrophil levels returned to baseline. Predictably, GM-CSF administration results in accelerated neutrophil recovery in patients with chemotherapy-induced neutropenia. GM-CSF has also been shown to induce microbial killing by neutrophils and monocytes in vitro. This activity translated into a dose-related protection of GM-CSF-pretreated mice infected with lethal doses of micro-organisms. Interleukin-3 (IL-3) increases the cellularity of the bone marrow and GM-CSF can induce mobilization of bone marrow cells into the peripheral blood. Therefore, it was predicted and subsequently proved that a combination of these cytokines is synergistic, increasing the yields of peripheral blood progenitor cells which could be collected and then retransplanted into patients undergoing myeloablative chemotherapy. Monkeys injected with recombinant human IL-3 and GM-CSF had increased antibody titres to human IL-3 compared with monkeys given IL-3 alone, suggesting a potential use of GM-CSF which was not predicted from its in vitro results, that of vaccine adjuvancy. Thus, for any new mediator a broad range of tests of its activity in vitro may enable prediction of its activity in vivo, but it is also important to document any unexpected effects in in vivo studies which may give indications of new uses.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 7
    ISSN: 1432-0584
    Keywords: CTL-p ; Cytokines ; Limiting dilution analysis
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary Experimental animal and human in vivo studies have previously demonstrated the impact of exogenous administration of various cytokines on frequencies of circulating myeloid and LAK precursor cells. For the first time we investigated whether exogenous cytokines, in the absence of antigeneic challenge, may also influence frequencies of circulating antigenspecific cytotoxic T-lymphocyte precursor cells. We further asked whether triggering of autoimmune pathways as has been reported for several cytokines can be confirmed on the cellular level by demonstration of induction of autoreactive CTL-p. Limiting dilution analysis was used to determine alloreactive CTL-p frequencies in 31 patients with nonhematologic diseases before and after short-term systemic treatment with either rIL-2 (4.8×106 IU/m2 bid), rIL-3 (2.5, 5.0 or 10.0μg/kg qd), rGM-CSF (5μ/kg qd), rIFN-gamma (200 or 400μg qd), or IFN-alpha (3 or 5×106 IU qod). Simultaneously, autoreactive CTL-p frequencies were determined by split-well analysis in 25 of these patients. We found that rIL-2 significantly expands the circulating precursor pool of alloreactive CTL (p〈0.05). rIL-3 affected CTL-p frequencies in a dosedependent fashion. Low and intermediate doses of rIL-3 did not exhibit significant effects, whereas 10μg/kg rIL-3 led to expansion of alloreactive CTL-p in the same order of magnitude as did rIL-2. This effect was statistically significant when compared with rGM-CSF (p〈0.02), which apparently had no influence on alloreactive CTL-p frequencies. In contrast to rIL-2 and rIL-3, exogenous rIFN-gamma markedly reduced the circulating precursor pool of CTL. This again was statistically significant compared with rIFN-alpha (p〈0.03), which, like rGM-CSF, did not exhibit any effects on the level of alloreactive CTL-p. Frequencies of autoreactive CTL-p were invariably below the limit of detection in our system (〈1/300000). In conclusion, these data demonstrate that (a) short-term systemic administration of rIL-2, rIL-3, and rIFN-gamma differently affects the clone size of circulating precursors of alloreactive CTL in man, while rGM-CSF and rIFN-alpha do not exhibit measurable effects, and (b) none of the cytokines administered is capable of uncovering detectable frequencies of autoreactive CTL-p.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 8
    ISSN: 1432-0584
    Keywords: Key words Interleukin-6 ; Donor treatment ; Bone marrow transplantation ; Platelet recovery
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract  We transplanted bone marrow cells derived from normal donor mice treated with IL-6 to study the effect on the hematopoietic recovery of lethally irradiated (8.5 Gy) recipients. Male Balb/C mice were treated for 7 days by continuous infusion of IL-6 (10 μg/day). Not only did these donor mice have increased numbers of circulating platelets as was previously shown; the numbers of circulating progenitor cells also increased more than 25-fold. Transplantation of nucleated bone marrow cells derived from these donor mice into lethally irradiated female recipients resulted in increased platelet nadir counts in comparison to recipients of normal bone marrow cells and similar to nadir counts of recipients of normal donor bone marrow treated with IL-6 for 7 days after transplantation. Combination of transplantation of bone marrow derived from IL-6 treated donors with post-transplantation treatment of the recipients with IL-6 resulted in a further increase in nadir counts, although it did not cause a further acceleration of platelet reconstitution. We conclude that transplantation of bone marrow cells modified in vivo by IL-6 results in significantly accelerated reconstitution of platelets, to a degree similar to that observed following treatment with IL-6 after transplantation.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 9
    Electronic Resource
    Electronic Resource
    Springer
    Infection 6 (1978), S. 221-227 
    ISSN: 1439-0973
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Summary A new influenza subunit vaccine which contains only hemagglutinin and neuraminidase antigens was investigated for reactogenicity and immunogenicity in children aged between three and 15 years. Children under six years of age received either 500 IU or 1000 IU of the commercial vaccine, those aged from six to 15 years either 1000 IU or 2000 IU. The vaccines contained the virus strains recommended by the World Health Organisation for the vaccination season 1976/77. In a double blind study the vaccinees were allocated at random to the different dosage groups. The children were examined for reactions by the vaccinating physician 24 hours after vaccination. Serum hemagglutination inhibiting antibody titers were determined before vaccination and four weeks after vaccination. In the younger age-group additional antibody determination was made two weeks after a booster injection. A very low rate of side-reactions was observed in all dosage groups. The increase of the antigen content was not associated with a higher rate of side reactions. After the first vaccination a significant rise of antibody titers could be observed in all children. After the booster injection a further increase of these antibody titers was observed. The response of the younger age group to the dosages 500 and 1000 IU did not differ significantly. In contrast, in the older age group the increase of the dosage from 1000 to 2000 IU was connected with a better immune response. This was especially marked in the antibody titers against the influenza B-strain virus.
    Notes: Zusammenfassung Eine neue, praktisch nur Hämagglutinin und Neuraminidase enthaltende Influenza Subunit Vakzine wurde im Hinblick auf Verträglichkeit und Immunogenität bei Kindern im Alter von 3 bis 15 Jahren untersucht. Der im Handel befindliche Impfstoff wurde bei Kindern unter sechs Jahren mit einer Dosierung von 500 IE und 1000 IE, bei Kindern ab sechs Jahren mit einer Dosierung von 1000 IE und 2000 IE vergleichend untersucht. Der Impfstoff enthielt die von der World Health Organisation für die Impfsaison 1976/77 empfohlenen Virusstämme. Die Impfung wurde als Doppelblindstudie durchgeführt, wobei die Impflinge zu den verschiedenen Dosierungen randomisiert zugeordnet wurden. Die Kinder wurden 24 Stunden nach der Impfung im Hinblick auf Nebenwirkungen vom Impfarzt untersucht. Die Hämagglutinations-hemmenden Antikörper wurden vor der Impfung, vier Wochen nach der Impfung und zwei Wochen nach der Booster-Impfung bei den jüngeren Kindern bestimmt. Die Nebenwirkungsrate war bei allen eingesetzten Dosierungen sehr niedrig. Die Erhöhung der Antigenmenge war nicht mit einer Erhöhung der Nebenwirkungsrate verknüpft. Die Beurteilung der Hämagglutinations-hemmenden Antikörpertiter ergab, daß bei allen Kindern bereits durch die Erstimpfung ein signifikanter Titeranstieg erzielt werden konnte. Durch eine Zweitimpfung ließen sich die Titer noch einmal deutlich steigern. Während bei den jüngeren Kindern die beiden Dosierungen 500 bzw. 1000 IE zu keinem statistisch signifikant unterschiedlichem Titeranstieg führten, war bei den älteren Kindern die Erhöhung der Dosis von 1000 auf 2000 IE mit einer besseren Immunantwort verbunden, was besonders bei den Titern gegen den B-Stamm zum Ausdruck kam.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 10
    ISSN: 1439-0973
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Summary The antibody response to a new influenza subunit vaccine was compared one year after vaccination with the responses induced by two other influenza vaccines. The subunit vaccine was given either in a high dose form containing 2100 IU, or in a low dose form containing 700 IU. As comparison a split vaccine was used containing 800 IU and AI(OH)3 as adjuvant and a whole virus vaccine containing 2100 IU. Of the 399 vaccinated subjects which had taken part in this study 151 were available for hemagglutination inhibiting (HAI) antibody determinations one year after vaccination. Protection rates were assessed for the respective groups on the assumption that serum HAI titers of 1:32 or greater confer protection. With the high dose of subunit vaccine 85% of volunteers were considered still to have protective titers one year after vaccination, compared with 77% of those who received the whole virus vaccine. Although the high dose subunit vaccine and whole virus vaccine induced similarly high protective levels lasting at least one year, the reactions observed on vaccination were significantly less wit the subunit prepration. The lower dose of subunit vaccine induced lower levels of protection (60%) after one year, and lower mean HAI titers than the high dose subunit vaccine. Nevertheless protection was superior to that of the split virus adjuvant vaccine. The addition of adjuvant thus does not seem materially to improve the immune response to influenza virus antigens. An increase of antigen content can however be seen as a practical alternative for achieving higher antibody levels. The subunit vaccine would appear to be particularly suitable in this respect as even with a higher dose there is no increase in reactogenicity.
    Notes: Zusammenfassung Der Antikörperspiegel ein Jahr nach der Impfung mit einer Influenza Subunit-Vakzine wurde verglichen mit der Immunantwort, die durch zwei andere Influenzavakzinen hervorgerufen wurde. Die Subunit-Vakzine wurde mit einer hohen Dosierung von 2100 IE und in einer niedrigen Dosierung von 700 IE verabreicht. Im Vergleich dazu wurde eine Spaltvirus-Vakzine mit 800 IE und AL(OH)3 und eine Ganzvirus-Vakzine mit 2000 IE eingesetzt. Von den 399 geimpften Personen, welche an dieser Untersuchung teilgenommen haben, standen 151 für die Bestimmung der hämagglutinationshemmenden Antikörpertiter ein Jahr nach der Impfung zur Verfügung. Schutzraten für die jeweiligen Gruppen wurden bestimmt unter der Annahme, daß ein HAI-Titer von 1:32 oder darüber als schützend zu betrachten ist. Mit der hochdosierten Subunit-Vakzine waren ein Jahr nach der Impfung noch 85% der Geimpften im schützenden Titerbereich, im Vergleich dazu 77% der mit Ganzvirus-Vakzine geimpften Personen. Die hochdosierte Subunit-Vakzine und die Ganzvirus-Vakzine stimulierten ähnlich hohe Schutzraten, die über ein Jahr anhielten. Jedoch verursachte die Subunit-Vakzine signifikant weniger Nebenreaktionen. Die niedriger dosierte Subunit-Vakzine führte zu einer niedrigeren Schutzrate (60%) nach einem Jahr. Auch die Mittelwerte der HAI-Titer lagen niedriger im Vergleich zu jenen der hochdosierten Subunit-Vakzine. Trotzdem war sie in bezug auf Schutzrate besser als die Spaltvirus-Vakzine. Der Zusatz eines Adjuvans scheint daher nicht maßgeblich zu sein, um die Immunantwort von Influenza-Antigenen zu verbessern. Ein erhöhter Antigengehalt hingegen könnte als praktische Alternative angesehen werden, um höhere Antikörperspiegel zu erzielen. Die Subunit-Vakzine dürfte hiefür besonders geeignet sein, da sie auch bei höherer Dosierung zu keiner erhöhten Nebenwirkungsrate führt.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...